➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Harvard Business School
McKinsey
Express Scripts
Mallinckrodt

Last Updated: April 18, 2021

DrugPatentWatch Database Preview

ATAZANAVIR SULFATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

DrugPatentWatch® Litigation and Generic Entry Outlook for Atazanavir Sulfate

A generic version of ATAZANAVIR SULFATE was approved as atazanavir sulfate by TEVA PHARMS USA on April 22nd, 2014.

  Start Trial

Drug patent expirations by year for ATAZANAVIR SULFATE
Drug Prices for ATAZANAVIR SULFATE

See drug prices for ATAZANAVIR SULFATE

Recent Clinical Trials for ATAZANAVIR SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GlaxoSmithKlinePhase 4
ViiV HealthcarePhase 4

See all ATAZANAVIR SULFATE clinical trials

Medical Subject Heading (MeSH) Categories for ATAZANAVIR SULFATE
Paragraph IV (Patent) Challenges for ATAZANAVIR SULFATE
Tradename Dosage Ingredient NDA Submissiondate
REYATAZ CAPSULE;ORAL atazanavir sulfate 021567 2010-03-19
REYATAZ CAPSULE;ORAL atazanavir sulfate 021567 2010-02-16
REYATAZ CAPSULE;ORAL atazanavir sulfate 021567 2009-07-20

US Patents and Regulatory Information for ATAZANAVIR SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal ATAZANAVIR SULFATE atazanavir sulfate CAPSULE;ORAL 209717-001 Jun 1, 2020 DISCN No No   Start Trial   Start Trial   Start Trial
Teva Pharms Usa ATAZANAVIR SULFATE atazanavir sulfate CAPSULE;ORAL 091673-003 Apr 22, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma Ltd ATAZANAVIR SULFATE atazanavir sulfate CAPSULE;ORAL 204806-003 Jun 25, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Amneal ATAZANAVIR SULFATE atazanavir sulfate CAPSULE;ORAL 209717-004 Jun 1, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
Cipla ATAZANAVIR SULFATE atazanavir sulfate CAPSULE;ORAL 200626-004 Aug 9, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
AstraZeneca
Johnson and Johnson
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.